Glucose B.Braun (Glucose)

Glucose B.Braun is indicated for several clinical situations where rapid elevation of blood glucose or fluid replacement is required.

• Acute treatment of hypoglycemia to quickly raise blood glucose levels in both adult and pediatric patients.
• Provision of a carbohydrate source as part of total parenteral nutrition solutions for patients unable to receive enteral feeding.
• Adjunctive fluid therapy to replace volume and maintain hemodynamic stability during surgery or trauma care.
• Support for patients undergoing prolonged fasting, such as before diagnostic procedures, to prevent hypoglycemia.
• Facilitation of electrolyte balance when administered together with compatible salt solutions in intravenous therapy.

Glucose B.Braun may be associated with a range of adverse reactions, most of which are related to the intravenous administration of a carbohydrate solution.

Common

• Local irritation or pain at the injection site.
• Mild hyperglycemia with transient elevation of blood glucose.
• Nausea or vomiting, especially if administered rapidly.
• Headache or light‑headedness.
• Transient flushing or feeling of warmth during infusion.

-

Serious

• Severe hyperglycemia leading to osmotic diuresis or ketoacidosis in susceptible patients.
• Allergic reactions such as urticaria, rash, or anaphylaxis.
• Electrolyte disturbances (e.g., hypernatremia) when combined with inappropriate salt solutions.
• Volume overload causing pulmonary edema in patients with compromised cardiac function.
• Hypotension due to rapid infusion of large volumes.

-

When using Glucose B.Braun, clinicians should observe several precautions to ensure safe administration and to minimize the risk of complications.

• Verify patient’s blood glucose level before and during infusion to avoid excessive hyperglycemia.
• Adjust infusion rate according to individual tolerance and clinical condition.
• Use compatible IV sets and avoid mixing with incompatible drugs or solutions.
• Monitor fluid balance and electrolytes, especially in patients with renal or cardiac impairment.
• Assess for signs of allergic reaction during the first administration.
• Ensure aseptic technique to prevent contamination.

Glucose B.Braun can interact with other intravenous agents; awareness of potential interactions helps maintain therapeutic effectiveness and patient safety.

Avoid

• Co‑administration with high‑dose insulin infusions without close glucose monitoring.
• Mixing with calcium‑containing solutions that may precipitate.
• Concurrent use with hyperosmolar drugs that could exacerbate fluid overload.
• Administering with potassium chloride solutions without proper dilution, as high glucose may affect potassium distribution.

Use with caution

• Concurrent administration with diuretics; monitor electrolytes and fluid status.
• Use alongside beta‑blockers, as they may mask hypoglycemia symptoms.
• Combination with other carbohydrate solutions; adjust total glucose load to prevent hyperglycemia.
• Use in patients receiving corticosteroids, which can increase blood glucose levels; monitor closely.